Showing results (391-400 of 699) with videos related to
Sort By:
Pageof 70
Diabetes Care|December 27, 2023
Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin ResistanceThomas Ebert, Stefan D Anker, Luis M Ruilope, et al.Journal of Diabetes and Its Complications|February 12, 2026
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITYRobert Weingold, Gerasimos Filippatos, Stefan D Anker, et al.Scientific Reports|January 23, 2020
Describing the fecal metabolome in cryogenically collected samples from healthy participantsKajetan Trošt, Linda Ahonen, Tommi Suvitaival, et al.Journal of Diabetes and Its Complications|October 15, 2024
Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular diseaseLuis F Ferreira-Divino, Christina G Poulsen, Viktor Rotbain Curovic, et al.The Lancet. Diabetes & Endocrinology|January 18, 2016
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trialHiddo J L Heerspink, Frederik Persson, Barry M Brenner, et al.Diabetes Care|July 3, 2019
Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 DiabetesSascha Pilemann-Lyberg, Daniel Guldager Kring Rasmussen, Tine Willum Hansen, et al.Advances in Therapy|May 30, 2026
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi ConsensusYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.Diabetes, Obesity & Metabolism|September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trialPeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2024
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6Ellen M Apperloo, David Z I Cherney, Anja Birk Kuhlman, et al.Scientific Reports|September 9, 2024
Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetesTina Okdahl, Huda Kufaishi, Ditte Kornum, et al.Pageof 70